METASTATIC RENAL CELL CANCER
Clinical trials for METASTATIC RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a two-drug combo slow kidney cancer better than one?
Disease control OngoingThis study tests whether adding an experimental immune-boosting drug (anti-OX40 antibody) to the standard targeted therapy axitinib helps control advanced kidney cancer better than axitinib alone. About 62 adults whose cancer worsened after prior immunotherapy will receive either…
Matched conditions: METASTATIC RENAL CELL CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Inhaled therapy shows promise for lung metastases
Disease control OngoingThis study tests an inhaled form of a protein called interleukin-2 (IL-2) to treat cancers that have spread to the lungs, such as melanoma, kidney cancer, and sarcoma. The goal is to find the safest dose and see if it can shrink tumors. About 70 adults with advanced cancer and lu…
Matched conditions: METASTATIC RENAL CELL CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New test could spot kidney cancer early using blood and urine
Diagnosis OngoingThis study looks at whether measuring certain immune cells (MDSCs) in blood and urine can help detect kidney cancer early and monitor how it responds to treatment. Researchers will compare MDSC levels in healthy volunteers, patients with early-stage kidney cancer, and those with …
Matched conditions: METASTATIC RENAL CELL CANCER
Sponsor: University of Southern California • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC